BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33864144)

  • 1. Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy.
    Timmer FEF; Geboers B; Nieuwenhuizen S; Schouten EAC; Dijkstra M; de Vries JJJ; van den Tol MP; de Gruijl TD; Scheffer HJ; Meijerink MR
    Curr Oncol Rep; 2021 Apr; 23(6):68. PubMed ID: 33864144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Needle-guided ablation of locally advanced pancreatic cancer: cytoreduction or immunomodulation by in vivo vaccination?
    Geboers B; Ruarus AH; Nieuwenhuizen S; Puijk RS; Scheffer HJ; de Gruijl TD; Meijerink MR
    Chin Clin Oncol; 2019 Dec; 8(6):61. PubMed ID: 31865711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer.
    Bibok A; Kim DW; Malafa M; Kis B
    World J Gastroenterol; 2021 Jul; 27(27):4322-4341. PubMed ID: 34366607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
    van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
    J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
    He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
    Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation treatments in unresectable pancreatic cancer.
    Paiella S; De Pastena M; Romeo F; D'onofrio M; Fontana M; Pea A; De Marchi G; Crinò SF; Bassi C; Salvia R
    Minerva Chir; 2019 Jun; 74(3):263-269. PubMed ID: 30600963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous ablation of pancreatic cancer.
    D'Onofrio M; Ciaravino V; De Robertis R; Barbi E; Salvia R; Girelli R; Paiella S; Gasparini C; Cardobi N; Bassi C
    World J Gastroenterol; 2016 Nov; 22(44):9661-9673. PubMed ID: 27956791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
    Timmer FEF; Geboers B; Ruarus AH; Schouten EAC; Nieuwenhuizen S; Puijk RS; de Vries JJJ; Meijerink MR; Scheffer HJ
    Tech Vasc Interv Radiol; 2020 Jun; 23(2):100675. PubMed ID: 32591191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?
    de Liguori Carino N; O'Reilly DA; Siriwardena AK; Valle JW; Radhakrishna G; Pihlak R; McNamara MG
    Eur J Surg Oncol; 2018 Oct; 44(10):1486-1493. PubMed ID: 30146253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-disciplinary management of locally advanced pancreatic cancer with irreversible electroporation.
    Martin RCG
    J Surg Oncol; 2017 Jul; 116(1):35-45. PubMed ID: 28475814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined immunopharmaceutical therapy of patients with unresectable pancreatic carcinoma.
    Lygidakis NJ; Ziras FA; Kyparidou E; Parissis J; Papadopoulou P; Venetsanou B
    Hepatogastroenterology; 1995; 42(6):1039-52. PubMed ID: 8847017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of the locally advanced pancreatic cancer: An introduction and brief summary of techniques.
    Petrou A; Moris D; Paul Tabet P; David Wensley Richards B; Kourounis G
    J BUON; 2016; 21(3):650-8. PubMed ID: 27569086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible electroporation after induction chemotherapy versus chemotherapy alone for patients with locally advanced pancreatic cancer: A propensity score matching analysis.
    He C; Wang J; Zhang Y; Lin X; Li S
    Pancreatology; 2020 Apr; 20(3):477-484. PubMed ID: 32131993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for pancreatic cancer.
    Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
    Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.
    Alemi F; Alseidi A; Scott Helton W; Rocha FG
    Curr Probl Surg; 2015 Sep; 52(9):362-98. PubMed ID: 26363649
    [No Abstract]   [Full Text] [Related]  

  • 16. Microwave ablation of pancreatic tumors.
    Vogl TJ; Panahi B; Albrecht MH; Naguib NNN; Nour-Eldin NA; Gruber-Rouh T; Thompson ZM; Basten LM
    Minim Invasive Ther Allied Technol; 2018 Feb; 27(1):33-40. PubMed ID: 29278340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial.
    Walma MS; Rombouts SJ; Brada LJH; Borel Rinkes IH; Bosscha K; Bruijnen RC; Busch OR; Creemers GJ; Daams F; van Dam RM; van Delden OM; Festen S; Ghorbani P; de Groot DJ; de Groot JWB; Haj Mohammad N; van Hillegersberg R; de Hingh IH; D'Hondt M; Kerver ED; van Leeuwen MS; Liem MS; van Lienden KP; Los M; de Meijer VE; Meijerink MR; Mekenkamp LJ; Nio CY; Oulad Abdennabi I; Pando E; Patijn GA; Polée MB; Pruijt JF; Roeyen G; Ropela JA; Stommel MWJ; de Vos-Geelen J; de Vries JJ; van der Waal EM; Wessels FJ; Wilmink JW; van Santvoort HC; Besselink MG; Molenaar IQ;
    Trials; 2021 Apr; 22(1):313. PubMed ID: 33926539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation Strategies for Locally Advanced Pancreatic Cancer.
    Linecker M; Pfammatter T; Kambakamba P; DeOliveira ML
    Dig Surg; 2016; 33(4):351-9. PubMed ID: 27216160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
    Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
    Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage III pancreatic cancer and the role of irreversible electroporation.
    Al Efishat M; Wolfgang CL; Weiss MJ
    BMJ; 2015 Mar; 350():h521. PubMed ID: 25787829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.